BBC
Virtus Biotech Clinical Trials ETF Equity
Virtus
·Est. 2014
·US
·
virtus.com/products/virtus-biotech-clinical-trials-etf#shareclass./period.quarterly
·
← All ETFs
$44.17
-4.02%
(-1.85)
AUM $38.1M
Expense 65.00%
52w Low $16.76
87.2% of range
52w High $48.18
50d MA $43.08
200d MA $34.79
NAV
$44.83
AUM
$38.1M
Expense
65.00%
Holdings
198
Avg Volume
3K
Inception
Dec 16, 2014
Issuer
Virtus
Exchange
—
Domicile
US
ISIN
US26923G3011
50d MA
$43.08
200d MA
$34.79
About
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Sector Exposure
Healthcare
100.0%